IL303095B2 - שיטה ומערכת לבירור מאפיין תפקוד ריאה - Google Patents
שיטה ומערכת לבירור מאפיין תפקוד ריאהInfo
- Publication number
- IL303095B2 IL303095B2 IL303095A IL30309523A IL303095B2 IL 303095 B2 IL303095 B2 IL 303095B2 IL 303095 A IL303095 A IL 303095A IL 30309523 A IL30309523 A IL 30309523A IL 303095 B2 IL303095 B2 IL 303095B2
- Authority
- IL
- Israel
- Prior art keywords
- valve
- pressure
- examples
- sampling
- stage
- Prior art date
Links
- 230000009325 pulmonary function Effects 0.000 title claims description 11
- 238000000034 method Methods 0.000 title description 29
- 238000005070 sampling Methods 0.000 claims description 100
- 238000009423 ventilation Methods 0.000 claims description 28
- 230000001747 exhibiting effect Effects 0.000 claims description 15
- 238000005086 pumping Methods 0.000 claims description 9
- 239000007789 gas Substances 0.000 description 103
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 14
- 210000004072 lung Anatomy 0.000 description 13
- 238000005259 measurement Methods 0.000 description 13
- 230000008569 process Effects 0.000 description 12
- 229910052760 oxygen Inorganic materials 0.000 description 11
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 10
- 230000008859 change Effects 0.000 description 10
- 239000001301 oxygen Substances 0.000 description 10
- 238000010586 diagram Methods 0.000 description 9
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 8
- 230000007246 mechanism Effects 0.000 description 8
- 238000012544 monitoring process Methods 0.000 description 8
- 229910002092 carbon dioxide Inorganic materials 0.000 description 7
- 239000001569 carbon dioxide Substances 0.000 description 6
- 208000006673 asthma Diseases 0.000 description 5
- 230000000670 limiting effect Effects 0.000 description 5
- 210000002345 respiratory system Anatomy 0.000 description 5
- 238000013313 FeNO test Methods 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000000090 biomarker Substances 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 230000036961 partial effect Effects 0.000 description 4
- 230000002685 pulmonary effect Effects 0.000 description 4
- 238000013125 spirometry Methods 0.000 description 4
- 208000019693 Lung disease Diseases 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000013256 coordination polymer Substances 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000009613 pulmonary function test Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 208000037883 airway inflammation Diseases 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000004199 lung function Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000000414 obstructive effect Effects 0.000 description 2
- 230000010412 perfusion Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000002106 pulse oximetry Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229910001285 shape-memory alloy Inorganic materials 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- 208000010444 Acidosis Diseases 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 101710173835 Penton protein Proteins 0.000 description 1
- CYTYCFOTNPOANT-UHFFFAOYSA-N Perchloroethylene Chemical compound ClC(Cl)=C(Cl)Cl CYTYCFOTNPOANT-UHFFFAOYSA-N 0.000 description 1
- 208000010378 Pulmonary Embolism Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000007950 acidosis Effects 0.000 description 1
- 208000026545 acidosis disease Diseases 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000009530 blood pressure measurement Methods 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 230000005796 circulatory shock Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000013500 data storage Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 238000013213 extrapolation Methods 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000006213 oxygenation reaction Methods 0.000 description 1
- 230000001991 pathophysiological effect Effects 0.000 description 1
- 210000002976 pectoralis muscle Anatomy 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 210000000779 thoracic wall Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000002627 tracheal intubation Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000003519 ventilatory effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Measuring devices for evaluating the respiratory organs
- A61B5/087—Measuring breath flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Measuring devices for evaluating the respiratory organs
- A61B5/085—Measuring impedance of respiratory organs or lung elasticity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Measuring devices for evaluating the respiratory organs
- A61B5/087—Measuring breath flow
- A61B5/09—Measuring breath flow using an element rotated by the flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Measuring devices for evaluating the respiratory organs
- A61B5/091—Measuring volume of inspired or expired gases, e.g. to determine lung capacity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Measuring devices for evaluating the respiratory organs
- A61B5/097—Devices for facilitating collection of breath or for directing breath into or through measuring devices
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Physiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL303095A IL303095B2 (he) | 2023-05-21 | 2023-05-21 | שיטה ומערכת לבירור מאפיין תפקוד ריאה |
| PCT/IL2024/050495 WO2024241309A1 (en) | 2023-05-21 | 2024-05-21 | System for pulmonary function test and exhaled gas analyzer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL303095A IL303095B2 (he) | 2023-05-21 | 2023-05-21 | שיטה ומערכת לבירור מאפיין תפקוד ריאה |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| IL303095A IL303095A (he) | 2023-06-01 |
| IL303095B1 IL303095B1 (he) | 2024-09-01 |
| IL303095B2 true IL303095B2 (he) | 2025-01-01 |
Family
ID=92632012
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL303095A IL303095B2 (he) | 2023-05-21 | 2023-05-21 | שיטה ומערכת לבירור מאפיין תפקוד ריאה |
Country Status (2)
| Country | Link |
|---|---|
| IL (1) | IL303095B2 (he) |
| WO (1) | WO2024241309A1 (he) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20150265184A1 (en) * | 2014-03-20 | 2015-09-24 | Capnia, Inc. | Selection, segmentation and analysis of exhaled breath for airway disorders assessment |
| EP3558112B1 (en) * | 2017-03-06 | 2021-07-28 | Technopulm Ltd. | Device and method for estimation of pulmonary function characteristics |
| US11464426B2 (en) * | 2018-05-16 | 2022-10-11 | Massachusetts Institute Of Technology | Passive, proportional measurement of oxygen and carbon dioxide consumption for assessment of metabolic parameters |
| US20230022188A1 (en) * | 2019-12-02 | 2023-01-26 | Lung-Diagnostics Gmbh | Lung testing device |
-
2023
- 2023-05-21 IL IL303095A patent/IL303095B2/he unknown
-
2024
- 2024-05-21 WO PCT/IL2024/050495 patent/WO2024241309A1/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20150265184A1 (en) * | 2014-03-20 | 2015-09-24 | Capnia, Inc. | Selection, segmentation and analysis of exhaled breath for airway disorders assessment |
| EP3558112B1 (en) * | 2017-03-06 | 2021-07-28 | Technopulm Ltd. | Device and method for estimation of pulmonary function characteristics |
| US11464426B2 (en) * | 2018-05-16 | 2022-10-11 | Massachusetts Institute Of Technology | Passive, proportional measurement of oxygen and carbon dioxide consumption for assessment of metabolic parameters |
| US20230022188A1 (en) * | 2019-12-02 | 2023-01-26 | Lung-Diagnostics Gmbh | Lung testing device |
Also Published As
| Publication number | Publication date |
|---|---|
| IL303095A (he) | 2023-06-01 |
| IL303095B1 (he) | 2024-09-01 |
| WO2024241309A1 (en) | 2024-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7445601B2 (en) | Non-invasive device and method for the diagnosis of pulmonary vascular occlusions | |
| JP5706893B2 (ja) | 吐出された一酸化窒素を決定する方法及び装置 | |
| CN105025790B (zh) | 用于分析的呼吸选择 | |
| US8176915B2 (en) | End-tidal gas estimation system and method | |
| EP2124744B1 (en) | End-tidal gas estimation system and method | |
| AU2012354234B2 (en) | Method and device for measuring a component in exhaled breath | |
| EP1579882A1 (en) | Non-invasive method and apparatus for optimizing the respiration for atelectatic lungs | |
| EP1397072B1 (en) | Method and apparatus for measuring functional residual capacity (frc) and cardiac output (co) | |
| US7635339B2 (en) | Method for non-cooperative lung function diagnosis using ultrasound | |
| US7766857B2 (en) | Non-invasive determination of cardiac output, gas exchange and arterial blood gas concentration | |
| WO2023155612A1 (zh) | 一种多呼吸道的气体检测系统及其控制方法 | |
| EP2311371B1 (en) | Combination of inert gast rebreathing and multiple-breath wash-out techniques for determination of indices of ventilation inhomogeneity | |
| CN218391088U (zh) | 一种多呼吸道的气体检测系统 | |
| US20160345861A1 (en) | Method to Determine Indices of Ventilation Inhomogeneity e.g. Lung Clearance Index (LCI) of a Paediatric Test Subject | |
| Singer et al. | Exhaled nitric oxide in infants: a marker of inflammation? | |
| CN104391087A (zh) | 一种潮气呼气测定呼出气一氧化氮浓度方法及装置 | |
| IL303095B2 (he) | שיטה ומערכת לבירור מאפיין תפקוד ריאה | |
| US9999372B2 (en) | Combination of inert gas rebreathing and multiple-breath wash-out techniques for determination of indices of ventilation inhomogeneity | |
| US20250344964A1 (en) | Pulmonary disease screening system and method for screening pulmonary diseases using same | |
| Clifton et al. | A non-invasive method for estimating lung function | |
| Shade et al. | Design of respiratory devices | |
| Sylvester et al. | Respiratory measurement | |
| Scanlan et al. | Pulmonary Function Testing | |
| Brewer et al. | Evaluation of a CO2 Partial Rebreathing-Based Functional Residual Capacity Measurement Method for Mechanically Ventilated Patients | |
| Albertson | 3 The Use of the Pulmonary Function Laboratory in Diagnosing Asthma |